[
    [
        {
            "time": "",
            "original_text": "【权益变动】康龙化成(03759-HK)获FMRLLC增持26.41万股",
            "features": {
                "keywords": [
                    "康龙化成",
                    "FMRLLC",
                    "增持",
                    "权益变动"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【权益变动】康龙化成(03759-HK)获FMRLLC增持26.41万股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【异动股】康龙化成(03759-HK)涨3.15%",
            "features": {
                "keywords": [
                    "康龙化成",
                    "异动股",
                    "涨3.15%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】康龙化成(03759-HK)涨3.15%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "创新药板块热度不减，双鹭、海思科、丽珠、人福、贝达、康龙化成均大涨",
            "features": {
                "keywords": [
                    "创新药",
                    "板块热度",
                    "双鹭",
                    "海思科",
                    "丽珠",
                    "人福",
                    "贝达",
                    "康龙化成",
                    "大涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "创新药板块热度不减，双鹭、海思科、丽珠、人福、贝达、康龙化成均大涨",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759)：一体化CRO+CDMO服务平台深化融合 全球化发展立身科技前沿",
            "features": {
                "keywords": [
                    "康龙化成",
                    "CRO",
                    "CDMO",
                    "服务平台",
                    "全球化发展",
                    "科技前沿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成(300759)：一体化CRO+CDMO服务平台深化融合 全球化发展立身科技前沿",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]